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DE BOER, S. AND B. BOHUS. Effects of amphetamine and fS-endorphin fragments on maze performance in rats'. PHARMACOL 
BIOCHEM BEHAV 36(3) 555-561, 1990.--Fragments of 13-endorphin a d amphetamine cause similar effects in some tests of maze 
behavior in rats. The present study served to compare the influence of amphetamine and two 13-endorphin fragments [13-endorphin 
([3E)-(2-9) and I~E-(2-16)] on maze behavior in more detail. In Experiment I no significant effects of amphetamine and the peptides 
on behavioral performance in three selected Davenport configurations were found. In Experiment II amphetamine increased the 
frequency of errors and of returns to the start box, but only in the first trial. This effect was dependent on the rats' experience and on 
the maze configuration. In the next 11 trials, amphetamine slightly decreased the overall frequency of errors and of returns to the start 
box. Therefore, the effects of amphetamine onmaze behavior depend upon the extent of training experience and on the structure of 
the test mazes. The peptides did not significantly affect maze performance. It is concluded that the effects of amphetamine and the 
13-endorphin fragments on maze behavior are not comparable in this maze test. 
Rat maze behavior Hebb-Williams mazes Amphetamine 
13-Endorphin-(2-9) 13-Endorphin-(2-16) 
a-Type endorphins 13-Endorphin fragments 
BETA-ENDORPHIN [[3E-(1-31)] and its fragments influence rat 
behavior in various experimental situations. Effects have been 
found on, e.g., active and passive avoidance behavior (2, 7-9, 
11), habituation (11), exploratory and social behavior (15) and 
maze behavior (2,12). Some of these actions appeared to be 
similar to those of morphine, while others were different from 
"classical" opiate-like influences. One group of beta-endorphin 
fragments which show behavioral effects through nonclassical 
opioid mechanisms is that of the a-type endorphins, which 
consists of a-endorphin [[3E-(1-16)] and its fragments, e.g., 
[3E-(2-16), [3E-(1-9) and [3E-(2-9). Their behavioral effects 
resemble those of amphetamine in a number of respects. Amphet- 
amine as well as the a-type endorphins delay the extinction of pole 
jump behavior, facilitate passive avoidance behavior, increase 
substantia nigra self-stimulation and attenuate the grasping re- 
sponse of rats with lesions of the parafascicular area of the 
thalamus (10, 19-21). The peptides also enhance the apomor- 
phine-induced stereotyped sniffing (20). In a series of food- 
rewarded problem solving experiments in Hebb-Williams type of 
mazes, amphetamine, 13E-(2-9) and [3E-(2-16) increased the 
number of errors (2). The resemblance between the effects of 
amphetamine and a-type endorphins on rat behavior may mean 
that these substances work through at least partly similar mecha- 
nisms. Therefore, we were interested in a further comparison of 
the behavioral effects of amphetamine and a-type endorphins. 
Hebb-Williams type mazes were selected as a test situation. 
They have the advantage that drug effects on different aspects of 
the behavioral functioning can be picked up easier, because the 
test scores may be influenced by more than one process, e.g., 
changes in learning capacity, exploration, locomotor activity or 
motivation. However, because the behavioral changes leading to 
changes in error scores may be complex, it is necessary to analyze 
the behavioral changes into more detail if an effect is found. In 
previous experiments Bohus (2) found an increased number of 
errors in rats treated subcutaneously with 0.45 mg/kg amphet- 
amine, 0.125 mg/kg 13E-(2-9) and 0.125 mg/kg [3E-(2-16) one 
hour before the test sessions in three Rabinovitch-Rosvold (16) 
configurations. No further analysis of the underlying behavioral 
changes was performed. Therefore, it is possible that the behav- 
ioral effect of the endorphins was different from that of amphet- 
amine, even though the resulting changes in error score were 
similar. In a subsequent experiment (5), rats treated with 0.125 
mg/kg [3E-(2-16) one hour before the test sessions showed a 
decreased number of errorless trials in a series of 12 Davenport 
configurations (4). This effect was most pronounced in T3 and T9 
of the series, and absent in T1. Thus, the effect may be 
configuration dependent. In order to shorten the long series of 12 
configurations, we selected T1, T3 and T9 for further comparative 
study of effects of amphetamine and two a-type endorphins, 
[3E-(2-9) and 13E-(2-16) (Experiment I). 
In a second experiment (II) the same compounds were tested as 
in Experiment I. However, the experimental procedure was 
changed in such a way that eventual interactions of the drug effects 
with test configuration and with maze running experience of the 
rats could be detected. The animals were tested on two test days 
with an interval of seven days on which they were trained further 
in different configurations without treatment. Therefore, the drug 
effects were tested in a relatively early and a relatively late phase 
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FIG. 1. The test configurations used in the experiments. Dotted lines 
indicate the limits of the error zones. 1 = first error zone, 2 = second error 
zone. The letters in the blind alleys of T9 correspond tothose in Table 1. 
The arrow above T9 indicates the place of the start box for the calculation 
of the error patterns. For all configurations the start/goal boxes are situated 
in the upper ight and lower left comer of the maze. 
of the experiment, resulting in two clearly different levels of maze 
running experience. On each of the two test days two different 
maze configurations were used, half of the rats were tested in T9 
of the Davenport series and the other half were tested in a newly 
designed configuration T30. Rats were always tested in different 
configurations on the two test days. T9 from the Davenport series 
was selected because in this configuration an effect of [3E-(2-16) 
has been found previously. T30 is a symmetrical configuration (so 
that rats could run in two directions like in the Davenport 
configurations) with spatial characteristics related to those of the 
Rabinovitch-Rosvold series, in which more pronounced effects of 
amphetamine and o~-type ndorphins were found (2) than was the 
case in the Davenport series. The Rabinovitch-Rosvold configu- 
rations have smaller numbers of blind alleys with relatively large 
areas compared to the Davenport configurations. These properties 
seem to lead to larger numbers of errors per alley (6). The different 
types of configurations may test different aspects of the rats' maze 
running abilities and therefore also be differentially sensitive for 
detection of drug effects on maze behavior. 
METHOD 
Animals and Housing 
Male Wistar rats were housed 4 per cage. Experiments were 
performed in the light phase (light on: 0530-1930 hr), each day at 
about the same time. Water was supplied ad lib. 
Food Deprivation Schedule 
Immediately after the habituation sessions the food was taken 
away. Food was supplied after each pretraining or test session, 
immediately after the return of the last rat to the cage, for a period 
of 90 minutes. From Friday until Sunday morning food was given 
ad lib, no training or testing was performed in the weekend. On 
this deprivation scheme the body weights of the animals were 
reduced to about 80-90%. 
Drugs and Injections 
[3E-(2-9), 13E-(2-16) (Organon International BV, Oss, The 
Netherlands) and d-amphetamine sulfate (OPG, Utrecht, The 
Netherlands) were dissolved in 0.9% NaC1, which also served as 
the control solution. The doses were equal to those shown to be 
effective in earlier studies (2). Injections were always given 
subcutaneously (SC) in a volume of 0.5 ml/rat, 60 min before the 
test session (which was the same treatment-test interval as in 
previous studies). 
Apparatus 
The maze was constructed after the description of Daven- 
port and co-workers (4). The field was 60 x 60 cm, with end 
(= start/goal) boxes of 18 x 38 cm, walls of 20 cm high, and 
barriers of 10 cm high. Sliding doors separated the end boxes from 
the field. The whole apparatus was covered by wire mesh right 
above the barriers in the field, and above the walls of the end 
boxes. Food pellets were dropped into two dishes (diameter 5 cm), 
one in each end box. The only light source in the experimental 
room was a 40-W dim bulb fixed at a distance of 1 m above the 
centre of the bottom of the field of the maze. 
Training and Testing 
On the first day the rats were habituated by means of two 5-min 
exploration sessions (separated by at least 1 hour) in the maze 
without barriers, starting once from each of the two end boxes. 
Subsequently, the animals were pretrained in 5 different simple 
configurations, P1-P5 (6), and tested in more complex configu- 
rations. Throughout pretraining and testing one session per day 
was given, with 12 trials per session, and intertrial intervals of 15 
sec. The two end boxes served alternatingly as start and goal box. 
Reward consisted of two 45-mg Noyes pellets per trial. Animals 
that refused either to leave or to enter start- or goal-box or to eat 
in the pretraining phase, were discarded, as well as animals with 
a total running latency of 360 sec or longer in P5. 
Behavioral Measures 
Behavioral measures were: (A) The number of first zone errors 
(frequency of entering error zones marked with a 1 in Fig. 1). (B) 
The number of second zone errors (frequency of entering error 
zones marked with a 2 in Fig. 1). (C) The number of start box 
visits (the number of times a rat re-entered the start box with 4 
paws). (D) The number of errorless trials per session (the number 
of trials per session in which no errors were made). (E) The error 
pattern. The distribution of errors over the different error zones 
and its change in the course of the session were determined. For 
each trial the number of rats that visited a particular error zone at 
least once, was expressed as a percentage of the total number of 
rats in the corresponding treatment group (pattern of initial errors). 
In the same way for each particular error zone the percentage of 
rats per group that visited it at least twice was determined (pattern 
of repeated errors). 
Statistical Analysis 
Because of heterogeneity of the data, two nonparametric 
statistical tests were selected: the Kruskal-Wallis test, in case of 
significance followed by the Mann-Whitney U-test (3), and the 
k-sample test for aligned observations for unequal-sized samples 
(14). For all tests a significance level of 0.05 was used. Pairwise 
comparisons of groups were two-tailed, and were performed only 
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FIG. 2. The median of the number of first zone errors (left) and the median and 95% confidence limits of the 
total number of errorless trials (right) in each of the three test sessions in Experiment I, after subcutaneous 
treatment with saline (closed circles), 13E-(2-9) (closed triangles, 0.125 mg/kg), 13E-(2-16) (open triangles, 
0.125 mg/kg) or amphetamine (open circles, 0.45 mg/kg). [Number of rats per group: 10, except for the 
13E-(2-16) group in T3 and the amphetamine group in T9: n=9.] 
for the contrasts of the control group with each of the three 
experience groups. 
Experimental Procedures 
Experiment I. Forty male Wistar rats (body weight on the 
habituation day 147-187 g, approximate age 7 weeks) were tested 
subsequently in the configurations T1, T3 and T9 from the 
Davenport series (see Fig. 1). The experiment was performed in 
two equally sized replications. Behavioral measures were the 
number of errorless trials per session and the number of first zone 
errors in the first trial and summed over 12 trials. Second zone 
errors were not determined because in a previous study (5) we 
found no difference in the effects of 13E-(2-16) on first and second 
zone errors. 
The animals were distributed over the treatment groups at 
random per cage, so that each cage contained one animal from 
each treatment group. Groups of animals were treated with 
amphetamine (0.45 mg/kg), 13E-(2-9) (0.125 mg/kg), 13E-(2-16) 
(0.125 mg/kg) and saline (controls). On the second test day one 
animal from the ~E-(2-16)-treated group and on the third test day 
one animal from the amphetamine-treated group showed a startle 
response followed by refusal to run. These animals were discarded 
from the analysis but only on the mentioned test days. 
Experiment H. Once a week a new replication was started, 
using 160 rats in total (12 x 12 and 1 x 16 rats). Their body weight 
at the start of the experiment was 140-193 g (approximate age 7 
weeks). On the first test day the animals were treated and tested in 
T9 and T30, then trained further (without injections) in T2-T8 of 
the Davenport series, and again treated and tested in T30 or T9 on 
day 9. No animal was tested twice in the same configuration. 
On basis of the criteria mentioned for the pretraining proce- 
dure, five animals were discarded before the testing phase. The 
remaining 155 animals were divided in 3 equal classes on basis of 
their number of trials in P5 with a running latency _-< 10 sec at each 
weekly replication. For the test on day 1 the animals of each class 
were distributed at random over the four treatment groups [am- 
phetamine (0.45 mg/kg), 13E-(2-9) (0.125 mg/kg), 13E-(2-16) 
(0.125 mg/kg), saline]. For the test on day 9 the animals from each 
treatment group on day 1 were redistributed at random over the 
four groups in such a way that each treatment group on day 9 
contained 25% of the animals from each of the treatment groups on 
day 1. Two animals were discarded because of an experimentor's 
error (by accident 10 trials were given to a rat in the amphetamine 
group tested in T9 on day l, therefore only the data of the first trial 
of this rat were used) and illness (on day 9 one rat was dropped 
before the test started because of signs of illness), respectively. 
For data analysis, data on test day 1 were assumed to be 
independent from those on test day 9. The raw data of each 
subexperiment were tested with the Kruskal-Wallis test, in case of 
significance followed by the Mann-Whitney U-test. In addition, 
the k-sample test for aligned observations for unequal-sized 
samples was applied on pooled data of subexperiments aligned on 
the median of these subexperiments: T9 (pooled data of day 1 and 
day 9), T30 (pooled data of day 1 and day 9), day 1 (pooled data 
of T9 and T30), day 9 (pooled data of T9 and T30), pooled data 
of all four subexperiments. These tests on pooled data served to 
test if there were differences in effect either between the config- 
urations or between the test days, and if there were overall effects 
that could not be detected in the (smaller) subexperiments. 
In the first test trial in T9 and T30 data were collected for 
maximally 600 sec; animals that had not reached the goal within 
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FIG. 3. The effect of subcutaneous administration f amphetamine (0.45 
mg/kg), 13E-(2-9) (0.125 mg/kg) and 13E-(2-16) (0.125 mg/kg), per 
subexperiment, in Experiment II. Shown are the medians and 95% 
confidence limits for trial 1. (*p<=O.05, **p=<0.01.) 
this time were not tested further in that session. When an animal 
exceeded a criterion of 300 sec for any of the trials 2-12, its test 
session was discontinued and only the data of its first trial were 
used in the analysis. In total, nine rats exceeded these criteria but 
only on test day 1. Eight of these animals were tested in T9, two 
of which were treated with saline and the remaining six belonged 
to the amphetamine-treated group. The ninth animal was tested in 
T30 and treated with amphetamine. 
RESULTS 
Experiment I 
Figure 2 shows the frequency of the first zone errors in the 
course of the session and the number of errorless trials for each of 
the three test sessions. No significant treatment effects were found 
on these parameters. However, the amphetamine-treated animals 
showed a slightly higher median number of first zone errors but 
only in the first trial of T9 (in T9 4 of the 9 rats in the 
amphetamine-treated group made _-->7 first zone errors in the first 
TABLE 1 
THE SPATIAL DISTRIBUTION OF VISITS TO BLIND ALLEYS IN THE 





Saline Amphetamine 13E-(2-9) [3E-(2-16) 
22 A 81 95 71 83 
C 44 81 36 58 
F 56 56 33 60 
H 0 45 0 0 
24 A 19 50 35 17 
C 13 38 14 5 
F 0 13 0 20 
H 0 0 0 0 
27 A 0 32 6 6 
C 6 14 0 0 
F 0 0 0 0 
H 0 0 0 0 
Shown is the number of rats visiting the blind alleys (indicated with the 
letter of the corresponding first error zones, see Fig. 1 ) of T9 on day 1 in 
the first trial =>2 times, =>4 times or _-->7 times, expressed as the percentage 
of the number of rats in each treatment group visiting at least once. 
trial, whereas in each of the other three treatment groups only 1 or 
2 out of 10 animals had such score). 
Experiment H
The data of this experiment are summarized in Figs. 3 (trial 1) 
and 4 (trials 2-12). The peptides [3E-(2-9) and [3E-(2-16) did not 
significantly change the performance of the rats, neither in the first 
trial, nor in trials 2-12. 
In the first trial (Fig. 3), amphetamine treatment resulted in a 
significantly increased number of first and second zone errors in 
T9 on day 1 [Kruskal-Wallis test: H(3) = 14.17, p = 0.003 for first 
zone errors and H(3)= 12.54, p=0.006 for second zone errors, 
followed by Mann-Whitney U-test: U = 111.5, p = 0.002 for first 
zone errors and U = 127.0, p = 0.007 for second zone errors]. The 
k-sample test on the data pooled per test day showed a significant 
increase of first and second zone errors on day 1 (p-<_0.05), but not 
on day 9, indicating an interaction between the effect and 
experience level. The k-sample test on the data pooled per 
configuration showed a significant increase (p=<0.05) of first and 
second zone errors and start box visits in T9 but not in T30, 
suggesting an interaction between the effect and the test configu- 
rations. When pooled over both days and configurations the 
k-sample test showed a significant (pN0.05) increase in first zone 
errors in the amphetamine-treated group. These results suggest 
that amphetamine can cause a decreased maze performance, but 
this effect is dependent on maze experience and configuration. 
This effect of amphetamine can also explain the relatively high 
number (eight) of rats tested in T9 on day 1 that exceeded the 
latency criteria. Six belonged to the amphetamine group, two were 
treated with saline. With the exception of one saline- and one 
amphetamine-treated rat, all these animals exceeded the 600-sec 
criterion during the first trial. 
In trials 2-12 (Fig. 4), the number of start box visits was 
significantly decreased in the amphetamine-treated nimals in T30 
on day 1 [Kruskal-Wallis test: H(3)=8.41, p=0.038,  Mann- 
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FIG. 4. The effect of subcutaneous administration of amphetamine (0.45 mg/kg), 
13E-(2-9) (0.125 mg/kg) and 13E-(2-16) (0.125 mg/kg), per subexperiment, in Experiment 
II. Shown are the medians and 95% confidence limits for trials 2-12. (*p_--<0.05, 
**p_--<0.01 .) 
Whitney U-test: U=240.0,  p=0.013] as well as on day 9 
[Kruskal-Wallis test: H(3) = 8.17, p = 0.043, Mann-Whitney U- 
test: U = 320.5, p =0.008]. When the data were pooled per test 
day, a significant decrease of the number of start box visits was 
found with the k-sample test on both test days (p_---0.05), and a 
significant (p~0.05) decrease of the number of second zone 
errors, but only on day 9. When the data were pooled per 
configuration, the decrease of the number of start box visits was 
only significant (p_-<0.05) in T30, although also in T9 a slight 
decrease was present. When pooled over both days and configu- 
rations, the k-sample test showed a significant (p--<0.05) overall 
decrease of the number of second zone errors and of the number of 
start box visits. These results suggest hat, in addition to the 
decreased performance (as indicated by an increased number of 
errors and start box visits) found in the first trial on day 1 in T9, 
amphetamine can cause an increase in performance (as indicated 
by a decrease in errors and start box visits) in trials 2-12 that does 
not clearly interact with maze configuration or level of experience. 
Effects on Initial and Repeated Error Patterns 
The error patterns of the different subexperiments did not show 
clear differences between the experimental groups that could 
explain the treatment effect reported above, except for the pattern 
in T9 on day 1. The amphetamine-treated group has a higher 
percentage of initially visiting rats as compared to the other groups 
in error zones F, E, H and G ofT9 (see Fig. 1) on day 1, but only 
in the first trial. Repeated errors (percentage of rats visiting at least 
twice) were increased in the amphetamine-treated group in the 
same trial in all the error zones. Table 1 shows the number of rats 
visiting the first error zones of the four blind alleys in trial 1 at 
least 2, 4 or 7 times, expressed as a percentage of the number of 
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rats in the treatment group visiting at least once. These percentages 
are increased in the amphetamine-treated group. Amphetamine 
caused an increase of the number of rats repeating visits as well as 
the number of times they repeated. Although the amphetamine- 
treated rats visit all error zones more frequently, the general spatial 
pattern of their visits is still comparable to that of the other groups. 
In Table 1 the gradient over the blind alleys in perseverance 
percentage that is present in the saline- and peptide-treated rats, is 
in general also found in the amphetamine-treated rats. 
DISCUSSION 
No clear effects of the two [3-endorphin fragments were found. 
However, amphetamine increased the number of errors and start 
box visits in the first trial in T9 in animals with a relatively low 
level of previous maze running experience. This effect was 
statistically significant in Experiment II, but a tendency was also 
present in Experiment I. In trials 2-12, the amphetamine-treated 
animals performed at least as well or slightly better (a decreased 
number of errors and start box visits) than the placebo-treated rats. 
The effect in trials 2-12 was not dependent on configuration or test 
day. Although the results found in trials 2-12 may have been 
influenced by removal of those animals exceeding the time 
criterion in the first trial, the trends in the data for animals tested 
in T9 were comparable to those of the more complete data 
obtained in T30 on day 1 and both configurations on day 9. 
Especially the results from Experiment II suggest hat effects of 
a low dose of amphetamine on rat maze behavior are dependent 
on experience level of the rats as well as on maze configuration, 
and that qualitatively different effects can occur within one 
experiment. 
The disruptive ffect of amphetamine in the first trial in T9 on 
day 1 may be related to the well-known stereotyped behavior 
which can be elicited by amphetamine. Table 1 shows that the 
amphetamine-treated rats showed the same spatial pattern of errors 
as placebo-treated controls, but they repeated these errors more 
often. Amphetamine-induced stereotyped behavior and its dura- 
tion are known to be dependent on environmental nd other 
experimental factors (1,17). The expression of the effect of 
amphetamine in the first trial of T9 in an early phase of the test 
series may be related to the effort that the rat has to make to find 
the correct route in the maze. This effort may be higher if the level 
of experience is lower or if the maze configuration is more 
difficult. In terms of errors made by saline-treated rats, T9 can 
hardly be assumed to be more difficult than T30 or T3 (see Figs. 
2-4). However, T9 is the only one of these configurations in 
which part of the correct path shows an angle as large as 90 
degrees with the direction that rats probably prefer in these mazes, 
i.e., the direction corresponding to that of the diagonal from start 
to goal box (6). For the animals tested on day 1 in T9, this course 
of the path was new. Amphetamine treatment may have decreased 
the ability of the animals to adapt their previously successful 
strategy to the new orientation of the path in T9, but only until they 
found the goal box for the first time. After having completed the 
first trial or receiving training in other configurations (some of 
which have zigzagging routes like T9) on days 2-8, amphetamine 
does not disrupt their performance anymore. 
The slightly improved performance in amphetamine-treated 
rats found in trials 2-12 may have been caused by a generally 
increased learning ability, attention or motivation. The error 
patterns were not changed clearly in these trials. Increased 
performance in learning tests after treatment with amphetamine 
has been found previously by others (13,18). 
The fact that no effects were found of the two [3-endorphin 
fragments makes a qualitative comparison of amphetamine and 
endorphin effects on maze behavior difficult. Therefore, the 
results do not allow us to draw conclusions with respect o the 
previously reported similarity in effects of the investigated c~-type 
endorphins and amphetamine. The results of the present experi- 
ment and the difference in results between this study and those 
reported previously (2) suggest that experimental conditions inter- 
act with the investigated drug and peptide effects. Further exam- 
ination of the influence of methodological factors is essential to 
understand the effects of amphetamine and [3-endorphin fragments 
on rat maze behavior. 
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